12.22.2014
Medical Research
$272,395.00
12 months
Evaluation of FGF1 and derivatives in a Non-Human Primate (NHP) Model of Type 2 Diabetes
The Salk Institute for Biological Studies seeks to develop a potentially transformative therapeutic for treatment of type 2 diabetes.